A weekly intelligence briefing for your industry

Google Reader is back.
And it has a brain.

Kelp reads your industry's top sources and delivers a weekly briefing with the insights that matter — synthesized, sourced, and yours in eight minutes.

For analysts, executives, and policy professionals who can't keep up.

Start your free trial Free while in early access · No credit card ·
50+

trusted industry sources read on your behalf, every week.

8 min

to read your briefing — every link sourced, every claim cited.

3 hrs

of research saved each week — get the signal, skip the scroll.

Example Briefing

Healthcare Policy May 11 – May 17

93 articles analyzed

Executive Summary

FDA Commissioner Marty Makary resigned May 13 amid political pressure over drug approvals and e-cigarette regulations, triggering an urgent search for a successor focused on restoring agency trust [3][83][52]. The Trump administration moved to defer $1.3 billion in Medicaid funds to California over fraud suspicions while simultaneously proposing deregulation of AI safeguards in electronic health records [90][50]. Innovaccer secured multiple large-scale partnerships, including a statewide California Medi-Cal contract and collaborations with Allina Health and Carina Health Network, consolidating its position in AI-driven population health [35][18][61].

Key Takeaways

  • Vice President JD Vance deferred $1.3 billion in Medicaid reimbursements to California citing fraud suspicions, signaling intensified federal scrutiny of state program integrity.
  • HHS Secretary Robert F. Kennedy Jr. proposed removing user-centered design testing and AI transparency requirements for EHR vendors to accelerate market entry, drawing criticism from patient safety researchers.
  • Innovaccer won a $140 million statewide contract to manage data analytics for 2 million Medi-Cal patients in California, expanding its footprint in public sector value-based care.
  • Marty Makary's resignation as FDA Commissioner follows conflicts with the White House over fruit-flavored e-cigarettes and mifepristone restrictions, leaving the agency without confirmed leadership during critical policy shifts.

Key Themes

Federal Leadership Instability

Leadership turnover at the FDA and HHS is driving rapid policy reversals on drug approvals, vaping regulations, and reproductive health access.

Medicaid Fiscal and Political Pressure

States face increasing federal pressure on Medicaid funding integrity while simultaneously navigating new work requirements and immigration-related data sharing mandates.

AI Operational Automation

Health systems and payers are deploying AI platforms to automate prior authorization, revenue cycle management, and population health analytics at scale.

Regulatory & Policy Updates

FDA

FDA Commissioner Marty Makary Resigns Amid Political Conflict

Creates leadership vacuum affecting drug approval timelines and enforcement priorities for vaping and reproductive health products.

 CMS/MEDICARE

HHS Proposes Relaxing AI Safeguards for EHR Vendors

Removes mandatory user-centered design testing and model card transparency, potentially accelerating AI tool deployment but reducing oversight.

 STATE

Federal Government Defers $1.3B Medicaid Funds to California

Signals aggressive federal audit stance on state Medicaid programs; states must enhance fraud detection infrastructure to avoid payment freezes.

What to Watch

FDA Leadership Appointment

Q3 2026

Search for new FDA commissioner complicated by Senate scheduling and high White House expectations for food policy and drug reform.

Mifepristone Access Litigation

Late 2026

Supreme Court review of *Louisiana v. FDA* will determine long-term access to mail-order mifepristone following temporary stay expiration.

Medicaid Work Requirements

December 2026

Implementation of Medicaid work requirements in expansion states begins December 31, 2026, risking coverage losses for vulnerable populations.

Want one of these, but for your industry?

Start your free trial Read full briefing →

Explore Topics

Discover briefings in related industries

Artificial Intelligence

Machine learning, neural networks, and AI applications

Read briefing

Climate Tech

Climate technology, sustainability, and clean energy innovations

Read briefing

Questions

Does it hallucinate?
Every claim in your briefing links back to a real source. We use AI to summarize and synthesize, never to invent. If a fact can't be cited, it doesn't appear.
Where do the sources come from?
A curated set of trade publications, regulatory feeds, and primary documents per topic — vetted by humans. You can also add your own RSS feeds or paywalled outlets you have access to.
How is this different from ChatGPT or Perplexity?
They answer questions on demand. Kelp does the reading on schedule. Every Monday, an editor-grade brief lands in your inbox, structured the way an analyst would write it — without you having to ask.
Can I add my own sources?
Yes. Paste in any feed, blog, newsletter, or domain you'd want monitored. Kelp folds it into your weekly synthesis alongside the curated set.
What does it cost?
Kelp is free during early access — no credit card required. Paid plans will be introduced later; existing users will get plenty of notice.

Stop saving 40 articles
you'll never read.
Read one that has the answer.

Your first briefing arrives Monday morning. It takes eight minutes.

Start your free trial